Compare RVMD & CVNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | CVNA |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 46.8B |
| IPO Year | 2020 | 2017 |
| Metric | RVMD | CVNA |
|---|---|---|
| Price | $183.99 | $71.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 24 |
| Target Price | ★ $258.84 | $81.14 |
| AVG Volume (30 Days) | 1.9M | ★ 8.9M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 431.45 |
| EPS | N/A | ★ 8.45 |
| Revenue | N/A | ★ $20,322,000,000.00 |
| Revenue This Year | N/A | $46.30 |
| Revenue Next Year | $526.64 | $26.07 |
| P/E Ratio | ★ N/A | $9.18 |
| Revenue Growth | N/A | ★ 48.63 |
| 52 Week Low | $58.91 | $55.92 |
| 52 Week High | $224.31 | $486.89 |
| Indicator | RVMD | CVNA |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 72.91 |
| Support Level | $198.91 | $62.23 |
| Resistance Level | $207.50 | $418.77 |
| Average True Range (ATR) | 8.24 | 3.07 |
| MACD | 1.42 | 2.19 |
| Stochastic Oscillator | 86.26 | 95.97 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.